OBJECTIVE: To test the hypothesis that resistin is associated with insulin resistance and inflammation in pediatric patients with chronic kidney disease (CKD). STUDY DESIGN: This study is a cross-sectional analysis of 319 children in the Chronic Kidney Disease in Children cohort, a large cohort of children with stage II-IV CKD. Univariate and multivariate regression modeling was used to evaluate the association of serum resistin level with glomerular filtration rate (GFR), demographic data, and cardiovascular risk factors, including inflammatory cytokines, insulin resistance, and serum lipids. RESULTS: In univariate analyses, serum resistin level was negatively correlated with GFR (P < .01). Increased serum resistin was associated with elevated inflammatory cytokines, including interleukin (IL)-6 (P < .01), IL-10 (P < .01), and tumor necrosis factor-α (P < .01). Resistin level was not associated with insulin resistance, although it was positively correlated with serum triglycerides (P < .01) and negatively correlated with high-density lipoprotein cholesterol (P < .01). In multivariate analysis, GFR (β = -0.01; P < .001), IL-6 (β = 0.18; P < .001), IL-10 (β = 0.09; P = .01), and pubertal status (β = 0.18; P < .01) were significantly associated with serum resistin level. CONCLUSION: These results indicate that serum resistin level increases with GFR decline and is involved in the inflammatory milieu present in CKD.
OBJECTIVE: To test the hypothesis that resistin is associated with insulin resistance and inflammation in pediatric patients with chronic kidney disease (CKD). STUDY DESIGN: This study is a cross-sectional analysis of 319 children in the Chronic Kidney Disease in Children cohort, a large cohort of children with stage II-IV CKD. Univariate and multivariate regression modeling was used to evaluate the association of serum resistin level with glomerular filtration rate (GFR), demographic data, and cardiovascular risk factors, including inflammatory cytokines, insulin resistance, and serum lipids. RESULTS: In univariate analyses, serum resistin level was negatively correlated with GFR (P < .01). Increased serum resistin was associated with elevated inflammatory cytokines, including interleukin (IL)-6 (P < .01), IL-10 (P < .01), and tumor necrosis factor-α (P < .01). Resistin level was not associated with insulin resistance, although it was positively correlated with serum triglycerides (P < .01) and negatively correlated with high-density lipoprotein cholesterol (P < .01). In multivariate analysis, GFR (β = -0.01; P < .001), IL-6 (β = 0.18; P < .001), IL-10 (β = 0.09; P = .01), and pubertal status (β = 0.18; P < .01) were significantly associated with serum resistin level. CONCLUSION: These results indicate that serum resistin level increases with GFR decline and is involved in the inflammatory milieu present in CKD.
Authors: Muredach P Reilly; Michael Lehrke; Megan L Wolfe; Anand Rohatgi; Mitchell A Lazar; Daniel J Rader Journal: Circulation Date: 2005-02-14 Impact factor: 29.690
Authors: C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar Journal: Nature Date: 2001-01-18 Impact factor: 49.962
Authors: Juan J Díez; Pedro Iglesias; María J Fernández-Reyes; Abelardo Aguilera; María A Bajo; Pilar Alvarez-Fidalgo; Rosa Codoceo; Rafael Selgas Journal: Clin Endocrinol (Oxf) Date: 2005-02 Impact factor: 3.478
Authors: Thomas B Martins; Brian M Pasi; Jerry W Pickering; Troy D Jaskowski; Christine M Litwin; Harry R Hill Journal: Am J Clin Pathol Date: 2002-09 Impact factor: 2.493
Authors: Patrick J Sweigert; Vinod K Bansal; Debra A Hoppensteadt; Jennifer L Saluk; Daneyal A Syed; Jawed Fareed Journal: Int J Angiol Date: 2016-10-05
Authors: Mohammad Ali Ghaffari; Elham Mousavinejad; Forough Riahi; Masoumeh Mousavinejad; Mohammad Reza Afsharmanesh Journal: Neurol Res Int Date: 2016-11-28
Authors: Oleh Akchurin; Edwin Patino; Vidhi Dalal; Kelly Meza; Divya Bhatia; Simon Brovender; Yuan-Shan Zhu; Susanna Cunningham-Rundles; Eduardo Perelstein; Juhi Kumar; Stefano Rivella; Mary E Choi Journal: Kidney Int Rep Date: 2018-12-19